The early (intrauterine and neonatal) life environment plays an important role in programming the susceptibility in later life to chronic degenerative diseases, such as obesity, cardiovascular diseases, diabetes mellitus, cancer and osteoporosis.Among other hormones, leptin plays a major role in the regulation of the overall metabolism and has multiple neuroendocrine (adeno-and neuro-hypophysis axes and the hypothalamus-pituitary-adrenal axis) and immune functions.The hormone exerts its actions beginning in the early life time period, regulating the intrauterine and early extrauterine life growth and development, as well as the adaptation to extrauterine life, neonatal thermogenesis and response to stress. Recent findings also support a role of leptin in the process of fetal bone remodeling and brain development.Therefore, it is of interest to explore the physiology of leptin in early life, as well as those factors that may perturb the balance of the hormone with pathological consequences in terms of confining an increased risk for disease in later life.This review aims to summarize reported findings concerning the role of leptin in early life, as well as the association of fetal, maternal and placental factors with leptin levels, while attempting to speculate mechanisms through which these factors may influence the risk for developing chronic diseases in later life.
Int rauterine factors are important determinants of weight at birth, whereas a poor intrauterine milieu may program an increased susceptibility and, eventually, risk for developing chronic degenerative diseases in later life, such as obesity, hypertension, other cardiovascular diseases, type-2 diabetes mellitus and osteoporosis. [1] [2] [3] [4] [5] [6] With regards to carcinogenesis, in particular breast cancer, the association of fetal hormone levels with the stem cell potential has pointed to the early life roots of the disease in the sense that a highly estrogenic intrauterine environment may represent a 'fertile soil' for carcinogenesis in the breast tissue. 7 Apart from pregnancy estrogens, there has been an increasing interest in exploring the potential role of other components of the intrauterine and infantile hormonal environment in the causation of chronic diseases in later life, and leptin is a strong candidate among them.
Leptin, the product of the obesity (ob) gene, was discovered relatively recently (1994) and is a hormone of 16 kDa comprising 167 amino acids. 8 The central source of leptin is the adipose tissue (white and brown), although it can be also produced in other sites, including the placenta. 9 Leptin plays an essential role in the regulation of energy homeostasis, food intake and body composition beginning in the early life, when the hormone also controls overall fetal growth and development. 9 At the central nervous system (CNS) level, leptin exerts neurotrophic actions that control feeding during the critical period of development of the hypothalamus. Unlike what happens in later life, some findings from animal studies indicate that leptin does not inhibit the appetite during intrauterine and early postnatal life. On the contrary, it seems that leptin promotes swallowing activity and hyperphagia, therefore contributing to the rapid growth and weight gain of the newborn, but this evidence is still inconclusive. 10, 11 Thus, factors that influence fetal leptin levels may alter the programming of the appetite behavior by modifying the normal set-points, as well as the energy metabolism and adiposity. These changes further lead to an increased risk of developing cardiovascular and metabolic diseases in later life. 10, 12, 13 Children suffering from leptin deficiency due to a rare leptin gene mutation develop morbid obesity in early childhood, have no pubertal development and have important dysfunctions of growth and thyroid hormones. 14 Neonates that have either high leptin levels at birth (e.g., offspring of mothers with gestational diabetes) 15, 16 or low leptin levels (e.g., small for gestational age infants) 17 have a higher risk of developing obesity and type 2 diabetes mellitus compared with children who have normal leptin levels at birth. 18 Furthermore, some evidence from experimental studies supports the involvement of leptin in the formation of mammary glands, whereas both physiological and pathological breast cells express leptin. [19] [20] [21] Therefore, an adverse intrauterine environment that modifies leptin levels may perturb the reproductive path and increase the risk of breast cancer in adult life. Lastly, there is accumulating evidence that the risk of osteoporosis may also be determined by factors acting on the bone development during the intrauterine and infant life via the alterations in leptin dynamics. 22, 23 Given the importance of fetal adipose tissue and its hormones, including leptin, in terms of fetal growth and maturation for both survival at birth and overall health, we present a review of published evidence related to the role of leptin in early life physiology, specifically in relation to the reproductive function overall, energy homeostasis, infant growth, brain development and fetal bone remodeling. Moreover, an effort is made to summarize reports on the influence of fetal, maternal and placental factors in defining leptin levels with special focus on how these variables may affect the pathological risk in later life.
MULTIPLE ROLES OF LEPTIN IN HUMAN PHYSIOLOGY

Leptin in Relation to Energy Homeostasis
In adults, leptin regulates overall metabolism, including food intake, energy balance and body temperature by signaling satiety and decreasing the sensation of hunger at the hypothalamic level. 24 At the peripheral level, the hormone stimulates the process of oxidation of fatty acids in muscles, inhibits the accumulation of triglycerides in hepatic cells, 25 and has potent lipid-lowering effects in peripheral tissues and plasma that are thought to be essential for the prevention of cellular lipotoxicity and insulin resistance. 26 Basic functions of the organism, such as thirst and hunger-mediated ingestive behavior, are programmed in utero, and leptin seems to be an essential regulator in this process through its neurotrophic actions at the hypothalamic level. 10, 12, 13 There is some evidence from experimental studies, however debatable, that in early neonatal life, leptin may promote hyperphagia as an adaptive response to overcome the physiological weight loss observed during postnatal days 10, 11 and may also be a signal that initiates the enteric feeding. 26 The full extent of the involvement of this hormone in the regulation of these functions, however, has not been clarified.
Leptin in Relation to Growth and Development of the Fetus and the Infant
Different growth patterns in utero are accompanied by specific changes in leptin levels. 27 For instance, small for gestational age infants have lower leptin levels at birth than appropriate for gestational age children. On the contrary, large for gestational age neonates have higher leptin levels. 17, 18 Thus, leptin may be an important factor for growth and development of the fetus, whereas its effects seem independent of insulin and the growth hormone insulin-like growth factor-I system. 9 Recent studies suggest the implication of leptin in the regulation of some mitochondrial proteins, such as the uncoupling protein-1, specific to brown adipose tissue and critically important for the initiation of non-shivering thermogenesis of the newborn and during the transition from fetal to neonatal life. 26, 28 Leptin in Relation to Reproductive Function Leptin seems to be the physiological link between nutritional status and reproductive maturation, interfering with the regulation of adeno-and neuro-hypophysis (growth hormone, hypothalamo-pituitary-thyroid-axis, and hypothalamo-pituitary-adrenal and gonadal axes). 14, 25, 29, 30 It provides the CNS with information regarding the critical amount of adipose tissue and regulates the reproductive function at the central level via the gonadotropin-releasing hormone and hypothalamic-pituitary-gonadal axis, respectively. 29, 30 Furthermore, it has been shown that the secretion of leptin has a pulsatile rhythm, synchronized with that of the luteinizing hormone and estradiol. 30 Therefore, normal leptin levels are important prerequisites for both the onset of puberty and the maintenance of menstrual cycles and normal reproductive function. [31] [32] [33] [34] [35] Leptin in Relation to Stress In animal studies, leptin was found to inhibit responses to stress through enhancement of glucocorticoid receptor expression in CNS and sensitization of the glucocorticoid inhibitory feedback. 36, 37 These mechanisms are already present at birth and provide the newborn with a regulatory mechanism against the variation of adrenal hormones during the critical period of brain development. 36, 38 The role of leptin in human adrenal axis remains controversial, however. While some observational studies reported an inverse association between leptin and adrenocorticotropic hormone levels, other studies comprising subjects with mutations in leptin or the leptin receptor gene reported a normal adrenal function in these people. 39 
Leptin in Relation to Brain Development and Psychiatric Outcomes
The question whether leptin has direct involvement in the development of the brain has been explored in some experimental studies. Leptin is thought to be related to brain development, because leptin receptors are widely expressed in the brain and because brain weight as well as brain protein and DNA contents are reduced in adult leptin deficient mice (ob/ob). 40 This observation, however, has not been confirmed in the few studies of leptin deficiency in humans. 9 Another interesting finding of a recent report indicates a possible action of leptin as a cognitive enhancer in the hippocampus and on excitatory synaptic strength. 41 There is some clinical evidence among adults suffering from major psychiatric diseases that the balance of leptin is disturbed. 42 It is not clear, however, whether these changes in leptin levels reflect the modification of appetite behavior associated with these disorders or an involvement of leptin in the etiologic pathway of these conditions.
Leptin and Fetal Bone Remodeling
Leptin controls fetal bone remodeling by enhancing the differentiation of human bone marrow stromal cells to osteoblasts and decreasing bone resorption. [43] [44] [45] Along with the gradual increase in fetal leptin levels with the advancement of gestation, a significant inverse correlation between leptin and the markers of bone resorption has been reported. 43 It has been proposed that leptin might act, via sympathetic signaling, to modulate the proliferation of osteoblasts, but the exact mechanism of leptin action on bone formation has not been elucidated. 45 Other findings from animal studies show a positive association between early postnatal leptin levels in piglets and bone mass, along with a negative correlation between leptin and osteocalcine, a peptide that reflects the activity of osteoblasts. 46 Furthermore, in young ob/ob mice who lack leptin, an elevation of bone size, bone density and mineral content following treatment with leptin has been reported. [47] [48] [49] These findings, namely a strong association between leptin concentrations, body bone mineral contents and estimated bone density, have been recently confirmed in a study including human neonates. 23 Further studies are needed, however, to explore the function, site and mode of action of leptin on bone formation given the important implications of such a relation. If a direct link between leptin and intrauterine bone formation is clearly demonstrated, it may imply that the risk of osteoporosis in later life may be determined in early life through the regulatory mechanism of leptin, 23 indicating that interventions for prevention of osteoporosis should start in early life.
Other Roles of Leptin
Leptin promotes hematopoiesis and lymphopoiesis, stimulating the proliferation and differentiation of yolk sac cells, fetal liver cells and hematopoietic precursors. [50] [51] [52] However, the exact pathways and mechanisms have not yet been determined. At the intestinal level, leptin is implicated in the maturation of intestinal mucosa in the early stages of life and seems to have a protective effect against cell apoptosis and autophagy in the neonatal gut epithelium. 53 Finally, some animal studies indicate that leptin seems to contribute to pulmonary development in utero, as both the hormone and its receptor are expressed by fibroblasts and pulmonary epithelial cells, including fetal lung type II cells responsible for the secretion of pulmonary surfactant. 54, 55 SYNTHESIS AND DYNAMICS OF LEPTIN DURING PREGNANCY Leptin seems to be a critical factor for overall fetal development, as well as the evolution and maintenance of the pregnancy, while the regulation and the dynamics of the secretion of the hormone during pregnancy are extremely complex processes. The hormone is produced in both maternal and fetal adipose tissues and in the placenta, while its receptors are expressed in the uterine endometrium and trophoblast and the fetus. 56 
Maternal Leptin Levels
Circulating maternal leptin levels are substantially elevated during pregnancy due to the gradual increase of the body mass index throughout gestation, whereas the placenta seems to be an independent source of leptin. 57, 58 Increased levels of estradiol stimulate leptin production from adipocytes. The elevated cortisol and insulin levels during pregnancy seem to be involved in this process as well. 33 The dynamics of leptin follow the overall major metabolic changes during the gestational period, including the anabolic to catabolic shift, and provide further support that leptin is one of the essential factors regulating maternal and fetal energy balance. 9,57 A two-fold increase in leptin levels is observed in mid-pregnancy, which corresponds to the enhancement of bound leptin levels. 57 During labor, another significant increase of leptin levels is encountered, which is more pronounced in vaginal compared to Caesarean section delivery. Eventually, maternal leptin levels reach those of a physiological non-pregnant woman 3 to 6 days after delivery. 57, 59 Fetal Leptin Levels Fetal adipose tissue is an important source of leptin. Leptin has been identified in fat biopsies obtained from fetuses that died in utero between the 20 th and 38 th gestational week. 60 However, the production of the hormone seems to start earlier with lipidogenesis itself, as shown by immunocytochemical staining of developing subcutaneous tissues of human embryos at 6 to 10 weeks of gestation. 61 Leptin is produced primarily by white adipose tissue cells, while there is some evidence that brown adipose tissue is another source of fetal leptin. 26 The dynamics of fetal leptin levels follow the evolution of fetal adipose tissue. Thus, the limited development of fetal adipose cells prior to the ages of 32 to 34 weeks is followed by a significant increase of the adipose mass. 62, 63 Similarly, the low fetal leptin levels during the first half of gestation increase dramatically during the last part of the third trimester. 63, 64 The nonsignificant correlation between leptin levels, measured in fetal cord blood between the age of 14 to 32 weeks, and the pattern of growth emphasizes the importance of the development of adipose tissue in defining leptin levels. 64 Similar findings were reported in animal studies in which leptin was detected in fetal adipose tissue by the end of the second trimester with a significant increase up to term. 26 
Placental Leptin Levels
Human placenta expresses the ob gene, and syncytiotrophoblasts have been shown to synthesize leptin. 28, 65 Most of the placental produced leptin is released into maternal circulation and only a small percent is released to the fetus. 66 The sharp decline in maternal leptin levels following delivery or a spontaneous abortion may, in fact, reflect the cessation of the placental function. 57, 59 Several investigators have emphasized the contribution of the placenta as an additional source of fetal leptin. 26 In support of this theory is the positive correlation between placental and umbilical cord leptin levels, along with the independence noted between maternal and infant leptin levels. 28, 67 Umbilical Vein and Umbilical Artery Leptin Levels Throughout gestation, leptin concentrations are higher in the umbilical vein compared to those in the umbilical artery, and the difference increases significantly during the second half of pregnancy. 68 The difference persists at delivery, whereas a sharp decline in the leptin levels is observed on the 5 th postnatal day. 69 Notably, umbilical artery leptin seems to have a closer relationship to neonatal anthropometry, while umbilical vein leptin is more closely related to maternal characteristics. 70 In vaginal deliveries, leptin concentrations in both the umbilical artery and the umbilical vein are increased compared to those in Caesarean sections, indicating an augmented placental leptin release during advanced labor. 71 
FACTORS AFFECTING LEPTIN LEVELS AFTER DELIVERY Neonatal Leptin Levels
Two to three times higher serum leptin levels are observed among infants compared to those among adults. 72 The origin of newborn leptin from three different sources, the increased adipose leptin mRNA expression in fetal adipose tissue, and the onset of synthesis of leptin prior to the maturation of its receptor may explain this difference. 73 
Sociodemographic Factors
• Gender. At birth, female newborns have consistently been found to have higher leptin levels than males. [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] Underlying causes might be the differential amount of fat tissue by gender, the role of the variable sex steroid milieus of the newborn and the heavier placental weight associated with female gender. 72 95 Later on, however, children born with IUGR have higher serum leptin levels than children with normal birth weight, which may indicate an adaptative leptin resistance response which is beneficial for the catch-up growth of these children. 63 Lastly, large for gestational age infants have higher leptin levels at birth than appropriate for gestational age neonates, which are positively correlated with ponderal index and umbilical cord levels of insulin. 17, [96] [97] [98] [99] [100] Prematurity Compared with healthy full-term babies, preterm neonates have lower leptin levels, which are correlated to their gestational age and birth weight, [101] [102] [103] [104] [105] [106] [107] and increase after the 33 rd gestational week as a reflection of respective increases of the adipose tissue. 103 Moreover, serum leptin seems to be associated with serum insulin and the insulin/glucose ratio, supporting the hypothesis that an 'adipoinsular axis' exists and likely is functional before the 34 th gestational week. 108 The administration of antenatal steroids to advance embryonic maturation has a dose-response relationship with leptin levels at birth. 108 
Stress -Septicemia
An intriguing finding that needs to be confirmed is the increase in leptin levels in neonates with bacterial septicemia, which declines after treatment. This strengthens the role of leptin as a stress-related hormone. 109 
Maternal Factors Pathological Conditions
Pathological conditions of mothers are followed by significant changes in leptin levels of their offspring. Children born to mothers who developed gestational diabetes or to mothers with type-1 diabetes mellitus have higher leptin levels at birth compared to those of non-diabetic mothers and are at higher risk for macrosomia. 16, 65, [110] [111] [112] Involvement of insulin in up-regulating leptin expression in the placenta could be postulated as an underlying mechanism. 112 Preeclampsia also influences the dynamics of leptin with higher leptin levels reported among neonates born to mothers with this placental insufficiency, possibly due to the adaptative mechanisms determined by hypoxia and subsequent stress. [113] [114] [115] [116] Likewise, leptin levels in neonates suffering from fetal distress and hypercapnia correlate well with pCO 2 . 117 
Maternal Smoking During Pregnancy
Smoking during pregnancy is known to be associated with lower birth weight of the offspring, but the findings are unclear with regards to the influence it exerts on leptin levels. It has been suggested that smoking might increase the production of catecholamines in infants and lead to lipolysis, which might be followed by a corresponding decrease in leptin levels. 118, 119 Lower leptin levels were found in some studies, [118] [119] [120] whereas no significant difference of the breast milk leptin levels between smoking and nonsmoking women has been reported. 119, 121 Maternal Nutrition and the Metabolic Status Maternal nutrition and metabolic status during pregnancy are of crucial importance. A poor intrauterine milieu determined by maternal nutritional disturbances of placental insufficiency may alter the metabolic balance in the fetus with severe implications in later life. [1] [2] [3] [4] Fetal programming has been recognized as having an essential contribution in defining the adult phenotype 1,12,122 and brain development is very sensitive to specific nutrient intake which is essential for cell membrane formation and myelinization. 123 Both maternal overfeeding and fasting during pregnancy perturb glucose equilibrium and have been associated with risk alterations of the offspring with regards to the development of metabolic diseases and other pathological conditions in adulthood. Studies with animal models found a correlation between undernutrition throughout pregnancy and obesity, hyperinsulinemia and hyperleptinemia, 124 while malnutrition during late gestation or in the first period of extrauterine life resulted in lower leptin levels at the onset of puberty. 125 Historical observations in humans showed that offspring of women exposed to famine during the Dutch Hunger Winter in their first trimester of pregnancy had increased adiposity, while those exposed during the third trimester of pregnancy had a significantly lower rate of obesity. 126 Moreover, early gestational famine gave rise to schizophrenia, while later gestational famine was related to a high risk of developing affective disorders requiring hospitalization in adulthood. 127 People exposed to famine in mid and early gestation also had a higher risk for obstructive airway disease. Therefore, it seems that fetal lungs can be permanently affected by nutritional challenges during periods of rapid growth. 128 While the role of nutrition, regulatory hormones and other factors in the etiology of these pathological conditions has been established overall, it has not yet been clarified whether leptin is an etiological factor itself or a proxy signaling the nutritional imbalances and triggering adaptative reactions.
Apart from the quantity, the quality of diet during pregnancy seems to play a role in defining leptin levels. Maternal deficiency of essential fatty acids during late gestation and lactation has been associated with decreased leptin levels of newborns in animal studies. Thus, a link between maternal dietary content and regulation of the amount of infant adipose tissue and leptin mRNA expression might be present. 129 Moreover, the umbilical cord concentration of fatty acids seems to determine leptin levels in later life. 130 
Infant Diet
Different growth patterns in the first year of life are likely to reflect different types of infant diets. Besides the quantitative differences in energy, protein and micronutrients intake between human and formula milk, there are also differences among the growth factors contained, in terms of quality and quantity. Because breast feeding seems to exert a protective effect against obesity in later life, 131, 132 it was reasonable to explore the relation between early life diet and leptin levels. The evidence is contradictory. Some studies reported lower leptin levels for breast fed infants compared to children fed with formula milk. 72, 133 It is possible that formula milk may either bring a substantial amount of leptin 134 or produce some allergic reactions that increase leptin levels. 72 Other studies found higher leptin levels among breast fed newborns and proposed that this association was due to the acquisition of leptin from breast milk. [135] [136] [137] A correlation between leptin levels in breast milk and patterns of perinatal growth has been suggested by some investigations. Mothers of full-term newborns had double leptin levels in breast milk compared to those of preterm babies, whereas a sharp decline of leptin from colostrum to transitional milk was evident in the former group. 138 Mothers giving birth to small for gestational age infants had reduced leptin levels in breast milk during the first 15 days after birth compared with appropriate for gestational age and large for gestational age children. 139 Human milk leptin concentration beyond the neonatal period, however, seems to only correlate well with maternal body mass index but not with the body mass index of these infants. 140, 141 Thus, breast milk leptin might have a significant role in growth, appetite and regulation of nutrition in infancy, especially during the early lactation period, and the production of leptin in breast tissue might be regulated according to the needs of the infant. 139 
THE ROLE OF EARLY LIFE LEPTIN IN LATER LIFE DEGENERATIVE AND CHRONIC DISEASES
The thrifty phenotype hypothesis emphasizes the importance of early life environment in programming the susceptibility to chronic diseases in later life. 1 The programming is an epigenetic phenomena, which means that the fetal genome may suffer alterations to induce adaptative responses during stressful states occurring during the critical period of development. In support of these findings, studies with identical twins have shown that intrauterine environmental factors may be more important in influencing the growth and development of the infant and differentiate the risk of disease in later life than genetic factors. For instance, the twin with a lower weight at birth has an increased risk of developing diabetes mellitus and obesity in later life compared with the other child. 142 Both children with low weight at birth and those with high birth weight, as well as neonates suffering from IUGR (a reflection of the consequences of different nutritional or hormonal imbalances and of other pathological events these children encountered during the intrauterine life), have an increased risk of developing obesity, diabetes mellitus and hypertension later in life. 2, 3, 143 As indicated, leptin levels are also altered in these children, which points to the role of this hormone in regulating intrauterine growth and development and defining the risk for pathology in later life.
Maternal diseases (e.g., gestational diabetes), as well as placental insufficiency in preeclampsia and fetal pathology, have also been associated with changes in leptin. Moreover, the nutrition of the mother during pregnancy, along with the diet of the infant afterwards, influences leptin levels. Breast feeding seems to provide the newborn with an important source of leptin, essential for adaptation during postnatal life. It is not clear, however, how formula milk may influence the balance of leptin and what health consequences of the changes are induced by artificial feeding.
Leptin signals to the CNS indicates the status of energy resources in terms of availability and promotes specific adaptative reactions, such as setting up a low metabolic waste regimen and influences the overall physiological intrauterine and early life growth and development. 10, 12, 13 Later life degenerative outcomes seem to result from the action of environmental factors (e.g., altered nutrition in early life) and the subsequent metabolic and hormonal events they trigger, and leptin is an important mediator of these reactions.
Furthermore, the association of fetal hormone levels with the stem cell potential is an indication that human cancer, in particular breast cancer, may have its origin in the early life time period. 7 Leptin has been studied in relation to cancer risk and especially with those cancers related to obesity, including breast cancer. Experimental studies have shown that leptin has antiapoptotic effects and promotes cellular growth. However, a direct link between leptin and carcinogenesis could not be demonstrated in clinical studies. 144 Finally, the exploration of the role of leptin as a bone remodeling regulator and its possible involvement in neuronal and pulmonary development is very important given the implications for prevention.
CONCLUSIONS
Leptin is a hormone that seems to play a critical role in the regulation of a wide spectrum of functions of organisms, including overall metabolism, immune function, reproductive maturation and bone formation. As indicated, leptin signals to the CNS the availability of energy resources, is likely to trigger adaptative reactions that influence physiological intrauterine and early life growth and development, and appears to contribute to infant adaptations and postnatal growth rates, including neonatal thermogenesis and stress responses.
Birth weight is strongly related to leptin levels, whereas maternal diseases and fetal pathology have also been associated with short-term changes in leptin levels. The nutrition of the mother during pregnancy, along with the diet of the infant afterwards, also influences leptin levels.
Some factors being associated with alterations in leptin levels have also been found to be predictive of adult disease occurrence. Thus, it is reasonable to infer that leptin plays a role in linking early life events and conditions with long-term consequences. The inability to undertake longitudinal studies from early to late life makes it difficult to directly evaluate the existence of such associations. Nevertheless, a role of leptin appears likely, although at this stage, it is difficult to document whether this is a major mediating role or a reflection of other more critical endocrine and growth-related processes. 
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